Prognostic significance of cytoplasmic p53 overexpression in colorectal cancer. An immunohistochemical analysis

European Journal of Cancer

Volumn 32, Issue 5, 1996, Pages 802-806

  Flamini, G ^a   Curigliano, G ^a   Ratto, C ^a   Astone, A ^a   Ferretti, G ^a   Nucera, P ^a   Sofo, L ^a   Sgambato, A ^a   Boninsegna, A ^a   Crucitti, F ^a   Cittadini, A ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Colorectal cancer; Cytoplasm; Immunohistochemistry; p53 protein; Prognosis

Indexed keywords

PROTEIN P53;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; CELL NUCLEUS; COLONIC NEOPLASMS; CYTOPLASM; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PROGNOSIS; RECTAL NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030000199     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/0959-8049(95)00625-7     Document Type: Article

References (31)

1. Fearon ER, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990, 61, 759-767.
2. Groden J, Thliveris A, Samowitz W, et al. Identification and characterization of the familial adenomatous polyposis coli gene. Cell 1991, 66, 589-600.
3. Hamilton SR. Molecular genetics of colorectal carcinoma. Cancer 70, 1216-1221.
4. Itoh F, Hinoda Y, Ohe M, et al. Decreased expression of DCC mRNA in human colorectal cancer. Int J Cancer 1992, 53, 260-263.
5. Kinzler KW, Nilbert MC, Vogelstein B et al. Identification of a chromosome 5q21 gene that is mutated in colorectal cancers. Science 1991, 251, 1366-1370.
6. Baker SJ, Preisinger AC, Jessup M. p53 gene mutations occur in combination with 17p allelic deletions as late events in colorectal tumorigenesis. Cancer Res 1990, 50, 7717-7722.
7. Greenblatt MS, Bennett WP, Hollstein M, Harris CC. Mutations in the p53 tumour suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res 1994, 54, 4855-4878.
8. Slingerland JM, Jenkins JR, Benchimol S. The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation. EMBO J 1993, 12, 1029-1037.
9. Lane DP. p53, guardian of the genome. Nature 1992, 358, 15-16.
10. Tominaga O, Hamelin R, Trouvat V, et al. Frequently elevated content of immunochemically defined wild-type p53 protein in colorectal adenomas. Oncogens 1993, 8, 2653-2658.
11. Takahashi K, Suzuki K. DNA synthesis-associated nuclear exclusion of p53 in normal human breast epithelial cells in culture. Oncogene 1994, 9, 183-188.
12. Jerry DJ, Ozbun MA, Kittrell FS, Lane DP, Medina D, Butel JS. Mutations in p53 are frequent in the preneoplastic stage of mouse mammary tumor development. Cancer Res 1993, 53, 3374-3381.
13. Moll UM, Riou G, Levine AJ. Two distinct mechanisms alter p53 in breast cancer: mutation and nuclear exclusion. Proc Natl Acad Sci USA 1992, 89, 7262-7266.
14. Moll UM, La Quaglia M, Bénard J, Riou G. Wild-type p53 protein undergoes cytoplasmic sequestration in undifferentiated neuroblastomas but not in differentiated tumors. Proc Natl Acad Sci USA 1995, 92, 4407-4411.
15. van den Heuvel SJL, van Laar T, The I, van der EBA J. Large E1B proteins of Adenovirus types 5 and 12 have different effects on p53 and distinct roles in cell transformation. J Virol 1993, 67, 5226-5234.
16. Gannon JV, Lane DP. Protein synthesis required to anchor a mutant p53 protein which is temperature-sensitive for nuclear transport. Nature 1991, 349, 802-806.
17. Suzuki K, Ono T, Takahashi K. Inhibition of DNA synthesis by TGF-b1 coincides with inhibition of phosphorylation and cytoplasmic translocation of p53 protein. Biochem Biophys Res Commun 1992, 183, 1175-1183.
18. Zerrahn J, Deppert W, Weidemann D, Patschinsky T, Richards F, Milner J. Correlation between the conformational phenotype of p53 and its subcellular location. Oncogene 1992, 7, 1371-1381.
19. Takahashi K, Sumimoto H, Suzuki K, Ono T. Protein synthesis-dependent cytoplasmic translocation of p53 protein after serum stimulation of growth-arrested MCF-7 cells. Mol Carcinog 1993, 8, 58-66.
20. Ali IU, Schweitzer JB, Ikejiri B, Saxena A, Robertson JT, Oldfield EH. Heterogeneity of subcellular localization of p53 protein in human glioblastomas. Cancer Res 1994, 54, 1-5.
21. Weiss J, Schwechheimer K, Cavenee WK, Herlyn M, Arden KC. Mutation and expression of the p53 gene in malignant melanoma cell lines. Int J Cancer 1993, 54, 693-699.
22. Pezzella F, Morrison H, Jones M, et al. Immunohistochemical detection of p53 and bcl-2 proteins in non-Hodgkin's lymphoma. Histopathology 1993, 22, 39-44.
23. Van-Veldhuizen PJ, Sadasivan R, Cherian R, Dwyer T, Stephens RL. p53 expression in incidental prostatic cancer. Am J Med Sci 1993, 305, 275-279.
24. Sun XF, Carstensen JM, Zhang H, et al. Prognostic significance of cytoplasmic p53 oncoprotein in colorectal adenocarcinoma. Lancet 1992, 340, 1369-1373.
25. Sun XF, Carstensen JM, Stal O. Prognostic significance of p53 expression in relation to DNA ploidy in colorectal carcinoma. Virchows Archiv A Pathol Anat 1993, 423, 443-448.
26. Bosari S, Viale G, Bossi P, et al. Cytoplasmic accumulation of p53 protein: an independent prognostic indicator in colorectal adenocarcinomas. J Natl Cancer Inst 1994, 86, 681-687.
27. Midgley CA, Fisher CJ, Bartek J, Vojtesek B, Lane DP, Barnes DM. Analysis of p53 expression in human tumors: an antibody raised against human p53 expressed in Escherichia coli. J Cell Science 1992, 101, 185-189.
28. Vojtesek B, Bartek J, Midgley CA, Lane DP. An immunochemical analysis of human p53: new monoclonal antibodies and epitope mapping using recombinant p53. J Immunol Meth 1992, 151, 237-244.
29. Scott N, Sagar P, Stewart J, Blair GE, Dixon MF, Quirke P. p53 in colorectal cancer: clinicopathological correlation and prognostic significance. Br J Cancer 1991, 63, 317-319.
30. Rodrigues NR, Rowan A, Smith MEF, et al. p53 mutations in colorectal cancer. Proc Natl Acad Sci USA 1990, 87, 7555-7559.
31. Bell SM, Scott N, Cross D, et al. Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology 1993, 104, 57-64.